Hydrochloric Acid

Hydrochloric Acid

SCHEMBL10485992

C=Cc1ccccc1C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Cl-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.40
SNCA P37840 2/20 0.37
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10582315 0.89 HIF1A (0.34) HIF1ASNCAALDH1A1
Hydrochloric Acid SCHEMBL9292231 0.80 HIF1A (0.55) HIF1ASNCAALDH1A1TSHRCYP1A2
SCHEMBL2461048 0.79 CYP3A4 (0.40) ALDH1A1CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL3669415 0.77 ALDH1A1 (0.39) ALDH1A1TSHRCYP1A2CYP2D6
Bromide SCHEMBL2446627 0.75 HIF1A (0.55) HIF1ASNCAALDH1A1TSHRCYP1A2
Hydrochloric Acid SCHEMBL10486017 0.74 SNCA (0.41) HIF1ASNCAALDH1A1TSHRCYP1A2
Bromide SCHEMBL5671803 0.73 ALDH1A1 (0.39) ALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL28523066 0.73 ALDH1A1 (0.39) ALDH1A1TSHRCYP2C19
SCHEMBL7903417 0.72 ALDH1A1 (0.41) ALDH1A1TSHRCYP1A2
SCHEMBL29395089 0.71 ALDH1A1 (0.50) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3459975-B1 POLYMERIC ACID CATALYSTS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2024-10-02 EP claimed
EP-3166981-B1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2026-05-13 EP disclosed
US-12514267-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2026-01-06 US disclosed
US-12410206-B2 Oligosaccharide compositions and methods of use thereof for reducing ammonia levels DSM NUTRITIONAL PRODUCTS, LLC (US) 2025-09-09 US disclosed
US-20250057202-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2025-02-20 US disclosed
WO-2024203866-A1 THERMOSETTING RESIN, CURED PRODUCT THEREOF, AND THERMOSETTING COMPOSITION 第一工業製薬株式会社 2024-10-03 WO disclosed
WO-2024203867-A1 HEAT-CURABLE RESIN, CURED OBJECT FORMED THEREFROM, AND HEAT-CURABLE COMPOSITION 第一工業製薬株式会社 2024-10-03 WO disclosed
EP-3459975-B1 POLYMERIC ACID CATALYSTS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2024-10-02 EP disclosed
CN-113056488-B Oligosaccharide compositions and methods of use thereof for reducing ammonia levels DSM营养产品有限责任公司 2023-10-24 CN disclosed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
US-11697692-B2 Methods of producing glycan polymers DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-07-11 US disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 US disclosed
EP-3636077-B1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-11-16 EP disclosed
US-4837392-A Dry electrostatographic developer containing toner particles comprising a vinyl addition polymer containing a covalently bound quaternary phosphonium salt EASTMAN KODAK COMPANY (US) 1989-06-06 US disclosed
US-4837391-A HEAT RESISTANCE, COMPATAIBILITY EASTMAN KODAK COMPANY (US) 1989-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC HIF1A 1795/4885SNCA 4881/4885ALDH1A1 3518/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 HIF1A 2726/4885SNCA 4567/4885ALDH1A1 2641/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC HIF1A 1795/4885SNCA 4881/4885ALDH1A1 3518/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS HIF1A 1364/4885SNCA 4669/4885ALDH1A1 2993/4885
US-12410206-B2 Oligosaccharide compositions and methods of use thereof for reducing ammonia levels OAT, OTC, FUCA2 HIF1A 654/4885SNCA 4339/4885ALDH1A1 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.